Self-Association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its n-terminal region and is not required for its anti-interferon function

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 3307-3317

  Ortiz Riaño, Emilio ^a   Cheng, Benson Yee Hin ^a   de la Torre, Juan C ^b   Martínez Sobrido, Luis ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; SINGLE STRANDED RNA; VIRUS NUCLEOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BOLIVIAN HEMORRHAGIC FEVER; CONTROLLED STUDY; CYTOKINE RESPONSE; EMBRYO; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLECULAR PHYLOGENY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VIRAL GENETICS; VIRUS HEMORRHAGIC FEVER;

AMINO ACID MOTIFS; ANIMALS; CELL LINE; DOGS; HUMANS; INTERFERON TYPE I; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NUCLEOPROTEINS; VIRAL PROTEINS;

ARENAVIRUS; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACHUPO VIRUS;

EID: 84857947731     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05503-11     Document Type: Article

References (47)

1. Albertini AA, et al. 2006. Crystal structure of the rabies virus nucleoprotein-RNA complex. Science 313:360 -363.
2. Barton LL. 1996. Lymphocytic choriomeningitis virus: a neglected central nervous system pathogen. Clin. Infect. Dis. 22:197.
3. Borio L, et al. 2002. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287:2391-2405.
4. Borrow P, Martinez-Sobrido L, de la Torre JC. 2010. Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses 2:2443-2480.
5. Borrow P, Oldstone MB. 1994. Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology 198:1-9.
6. Brunotte L, et al. 2011. Structure of the Lassa virus nucleoprotein revealed by X-ray crystallography, small-angle X-ray scattering, and electron microscopy. J. Biol. Chem. 286:38748 -38756.
7. Buchmeier MJ, de la Torre JC, Peters CJ. 2007. Arenaviridae: the viruses and their replication, p 1791-1827. In Knipe DM, et al (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
8. Charrel RN, de Lamballerie X. 2003. Arenaviruses other than Lassa virus. Antiviral Res. 57:89 -100.
9. Clegg JC, Lloyd G. 1983. Structural and cell-associated proteins of Lassa virus. J. Gen. Virol. 64:1127-1136.
10. Das K, et al. 2008. Structural basis for suppression of a host antiviral response by influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 105:13093- 13098.
11. Eichler R, et al. 2004. Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res. 100:249 -255.
12. Fischer SA, et al. 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354:2235-2249.
13. Green TJ, Zhang X, Wertz GW, Luo M. 2006. Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. Science 313:357-360.
14. Gunther S, Lenz O. 2004. Lassa virus. Crit. Rev. Clin. Lab. Sci. 41:339- 390.
15. Harnish DG, Leung WC, Rawls WE. 1981. Characterization of polypeptides immunoprecipitable from Pichinde virus-infected BHK-21 cells. J. Virol. 38:840-848.
16. Hastie KM, Kimberlin CR, Zandonatti MA, MacRae IJ, Saphire EO. 2011. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3= to 5= exonuclease activity essential for immune suppression. Proc. Natl. Acad. Sci. U. S. A. 108:2396 -2401.
17. Hu CD, Kerppola TK. 2003. Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat. Biotechnol. 21:539 -545.
18. Isaacson M. 2001. Viral hemorrhagic fever hazards for travelers in Africa. Clin. Infect. Dis. 33:1707-1712.
19. Jahrling PB, Peters CJ. 1992. Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch. Pathol. Lab. Med. 116:486-488.
20. Kilgore PE, et al. 1997. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin. Infect. Dis. 24:718 -722.
21. Kochs G, Garcia-Sastre A, Martinez-Sobrido L. 2007. Multiple antiinterferon actions of the influenza A virus NS1 protein. J. Virol. 81:7011- 7021.
22. Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC. 2000. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J. Virol. 74:3470 -3477.
23. Levingston Macleod JM, et al. 2011. Identification of two functional domains within the arenavirus nucleoprotein. J. Virol. 85:2012-2023.
24. Martinez-Sobrido L, et al. 2009. Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 83:11330- 11340.
25. Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC. 2007. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol. 81:12696 -12703.
26. Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 80:9192-9199.
27. McCormick JB, Fisher-Hoch SP. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75-109.
28. McCormick JB, et al. 1986. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314:20 -26.
29. McKee KT, Jr, Huggins JW, Trahan CJ, Mahlandt BG. 1988. Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever. Antimicrob. Agents Chemother. 32:1304 -1309.
30. Mets MB, Barton LL, Khan AS, Ksiazek TG. 2000. Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. Am. J. Ophthalmol. 130:209 -215.
31. Munoz-Jordan JL, et al. 2005. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79:8004-8013.
32. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. 1998. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3= end formation of cellular pre-mRNAs. Mol. Cell 1:991-1000.
33. Neuman BW, et al. 2005. Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J. Virol. 79:3822-3830.
34. Ng AK, et al. 2008. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. FASEB J. 22:3638 -3647.
35. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 108:193- 199.
36. Noah DL, Twu KY, Krug RM. 2003. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3= end processing of cellular pre-mRNAs. Virology 307:386 -395.
37. Ortiz-Riano E, Cheng BYH, de la Torre JC, Martinez-Sobrido L. 2011. The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response. J. Virol. 85:13038 -13048.
38. Peters CJ. 2002. Human infection with arenaviruses in the Americas. Curr. Top. Microbiol. Immunol. 262:65-74.
39. Pinschewer DD, Perez M, de la Torre JC. 2003. Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J. Virol. 77:3882-3887.
40. Qi X, et al. 2010. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468:779 -783.
41. Rodriguez M, McCormick JB, Weissenbacher MC. 1986. Antiviral effect of ribavirin on Junin virus replication in vitro. Rev. Argent. Microbiol. 18:69 -74.
42. Rudolph MG, et al. 2003. Crystal structure of the Borna disease virus nucleoprotein. Structure 11:1219 -1226.
43. Shtanko O, et al. 2010. A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J. Virol. 84:5415-5422.
44. Snell N. 1988. Ribavirin therapy for Lassa fever. Practitioner 232:432.
45. Tawar RG, et al. 2009. Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science 326: 1279-1283.
46. Twu KY, Noah DL, Rao P, Kuo RL, Krug RM. 2006. The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target. J. Virol. 80:3957-3965.
47. Wu WW, Sun YH, Pante N. 2007. Nuclear import of influenza A viral ribonucleoprotein complexes is mediated by two nuclear localization sequences on viral nucleoprotein. Virol. J. 4:49.